Italy vs Sierra Leone: HIV/AIDS deaths averted by antiretroviral therapy
Italy
4,048 deaths
in 2024
Sierra Leone
4,079 deaths
in 2024
Italy rank
45th
Sierra Leone rank
44th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Italy
- Sierra Leone
How they compare
Sierra Leone currently reports 4,079 deaths against 4,048 deaths in Italy, a difference of 31 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Sierra Leone ahead.
Italy ranks 45th and Sierra Leone ranks 44th of 157 countries.
Italy has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Italy | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 710.23 deaths | 0 deaths | 710.23 deaths | Italy |
| 2000s | 4,451 deaths | 163.18 deaths | 4,288 deaths | Italy |
| 2010s | 4,398 deaths | 1,770 deaths | 2,629 deaths | Italy |
| 2020s | 4,155 deaths | 3,547 deaths | 607.71 deaths | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Italy or Sierra Leone?
- Sierra Leone, at 4,079 deaths against 4,048 deaths in Italy as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Italy and Sierra Leone?
- 31 deaths, with Sierra Leone ahead.
- How many years of comparable data are there for Italy and Sierra Leone?
- 35 years are reported by both, from 1990 to 2024.
- How do Italy and Sierra Leone rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Italy ranks 45th and Sierra Leone ranks 44th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.